TITLE:
Social Integration in Patients with Haematological Malignancies: Current Status, Influencing Factors and Intervention Strategies
AUTHORS:
Ziyun Wang, Qing Feng, Xueting Tian, Wenshu Teng, Fang Peng
KEYWORDS:
Haematological Malignancies, Social Integration, Influencing Factors, Social Support, Intervention Strategies, Review
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.14 No.6,
June
26,
2026
ABSTRACT: Social integration in patients with haematological malignancies is an important component of rehabilitation management and long-term survivorship care. This review aimed to synthesize the concept, assessment instruments, current evidence, influencing factors and intervention strategies related to social integration in this population. Relevant domestic and international literature was reviewed and summarized, with emphasis on conceptual definitions, measurement tools, research progress, associated factors and potential interventions. Social integration was identified as a dynamic and multidimensional process in which patients adapt to disease- and treatment-related changes, rebuild social connections, restore social roles and gradually reintegrate into society through productive activities, interpersonal relationships, community participation and leisure engagement. Commonly used assessment tools include the Community Integration Questionnaire, the Berkman-Syme Social Network Index, the Social Cohesion Scale and the Social Integration Scale for Cancer Patients. Existing evidence indicates that patients with haematological malignancies often experience psychological distress, heightened loneliness, occupational disruption and impaired social functioning due to the aggressive disease course, prolonged treatment trajectory and complex therapeutic regimens. Their social integration is mainly influenced by sociodemographic characteristics, disease- and treatment-related factors, psychosocial factors and healthcare-system factors. Psychoeducational interventions, peer-support programmes, digital health interventions and integrated care models may help alleviate negative emotions, enhance social support, improve self-management and promote continuity of care. Future large-scale, multicentre and longitudinal studies are needed to clarify the dynamic trajectory and underlying mechanisms of social integration, and individualized, continuous and multidisciplinary interventions should be developed to promote social reintegration and improve quality of life and long-term survivorship outcomes in patients with haematological malignancies.